Cargando…
Pharmacovigilance as a tool for safety and monitoring: a review of general issues and the specific challenges with end-stage renal failure patients
Pharmacovigilance is instrumental in helping to ensure patient safety for both newly released drugs and those that are well established in the market. However, while pharmacovigilance procedures are strictly regulated in the clinical trial setting, post-marketing adverse event reporting is not well...
Autores principales: | Jacob, Dalia, Marrón, Belén, Ehrlich, Jay, Rutherford, Peter A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636760/ https://www.ncbi.nlm.nih.gov/pubmed/23637559 http://dx.doi.org/10.2147/DHPS.S43104 |
Ejemplares similares
-
Safety and efficacy of vemurafenib in end stage renal failure
por: Iddawela, Mahesh, et al.
Publicado: (2013) -
End-stage renal failure associated with congenital deafness
por: Annear, Nicholas M P, et al.
Publicado: (2008) -
Emphysematous pyelonephritis leading to end-stage renal failure
por: Simms, Roslyn, et al.
Publicado: (2008) -
Pleural Effusion in End Stage Renal Failure Patients
por: Uzan, Gülfidan, et al.
Publicado: (2019) -
Changes in pharmacovigilance following the end of the Brexit transition
por: Hall, Sarah
Publicado: (2021)